Records containing: Lymphangioleiomyomatosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications
-
CLINICAL_TRIALS study record update · 2026-04-14Bronchodilator Effects of Nebulized Versus Inhaled Albuterol in Subjects With Lymphangioleiomyomatosis
-
CLINICAL_TRIALS study record update · 2026-04-06Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
-
CLINICAL_TRIALS study record update · 2026-02-18Discovery of Sirolimus Sensitive Biomarkers in Blood
-
CLINICAL_TRIALS study record update · 2026-01-23Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-21Feasibility Study of [11C]Acetate Positron Emission Tomography (PET) as an Indicator of Early Response to Rapamycin in Lymphangioleiomyomatosis (LAM) Patients
-
CLINICAL_TRIALS study record update · 2026-01-21A Phase 1, Randomized, Double-blinded, Placebo Controlled, Trial Evaluating the Long-term Safety and Tolerability of Imatinib for the Treatment of Lymphangioleiomyomatosis [LAMP-2 Trial]
-
CLINICAL_TRIALS study record update · 2025-07-08TSC Alliance Tuberous Sclerosis Complex (TSC) Biosample Repository and Natural History Database
-
CLINICAL_TRIALS study record update · 2025-03-13National Lymphangioleiomyomatosis Registry, France
-
CLINICAL_TRIALS study record update · 2024-12-24Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
-
CLINICAL_TRIALS study record update · 2024-12-24Multicenter International Durability and Safety of Sirolimus in LAM Trial (MIDAS)
-
CLINICAL_TRIALS study record update · 2024-07-30Exhaled Breath Proton Mass Spectrometry and Assessment of Endothelial Dysfunction in Patients With Respiratory Diseases
-
CLINICAL_TRIALS study record update · 2024-04-17Trial of Letrozole in Lymphangioleiomyomatosis
-
CLINICAL_TRIALS study record update · 2023-11-02Multicenter International Lymphangioleiomyomatosis Efficacy and Safety of Sirolimus Trial
-
CLINICAL_TRIALS study record update · 2023-03-29Study of New Potential Biomarkers of Lymphangioleiomyomatosis: Determination of Cathepsin K, Cystatin C, Collagen Telopeptides and Chondroitin Sulfates
-
CLINICAL_TRIALS study record update · 2023-02-10Biomarkers for Tuberous Sclerosis Complex: An International Multicenter Observational Longitudinal Protocol
-
CLINICAL_TRIALS study record update · 2023-02-01Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial (RESULT)
-
CLINICAL_TRIALS study record update · 2022-09-28A Pilot Study of Nintedanib for LymphAngioleioMyomatosis (LAM)
-
CLINICAL_TRIALS study record update · 2022-08-04Clinical Profile Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Followed at Hospital Das Clínicas, University of Sao Paulo Medical School
-
CLINICAL_TRIALS study record update · 2022-01-27Phase II Clinical Trial Evaluating the Effect of Loratadine Associated to Rapamicyn in Patients With Lymphangioleiomyomatosis
-
CLINICAL_TRIALS study record update · 2021-10-21Characterizing Lymphangioleiomyomatosis (LAM) With 11C-Choline PET/CT
-
CLINICAL_TRIALS study record update · 2021-08-02Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease
-
CLINICAL_TRIALS study record update · 2021-03-18Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis
-
CLINICAL_TRIALS study record update · 2020-11-19An Exploratory, Open-label, Non-randomized, Within-patient Multiple Dose-escalation Safety, Tolerability, PK and Efficacy Trial of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
-
CLINICAL_TRIALS study record update · 2020-08-25The Safety of Simvastatin (SOS) in Patients With Pulmonary Lymphangioleiomyomatosis (LAM) and With Tuberous Sclerosis Complex (TSC)